Thrombolex, Inc. — Form D

Thrombolex, Inc. of Kingston, NJ, a company, filed a Form D exempt-offering notice with the SEC on 2022-08-30. The offering totals $2.0M, of which $2.0M was reported sold. Industry: Other Health Care.

Offering

Issuer

Officers, directors & promoters (26)

Showing 25 of 26 people.

NameRoleLocation
Brian G FirthDirectorKingston, NJ
Brian G FirthExecutive OfficerKingston, NJ
Marvin J WoodallExecutive OfficerKingston, NJ
John A CerminaroExecutive OfficerKingston, NJ
Marvin J WoodallDirectorKingston, NJ
Kelly A ElliottDirectorKingston, NJ
Todd A RichmondDirectorKingston, NJ
Michael J CerminaroDirectorKingston, NJ
Michael J CerminaroExecutive OfficerKingston, NJ
Michael J CerminaroPromoterKingston, NJ
Tony J LitwillerExecutive OfficerKingston, NJ
Marvin WoodallDirectorRaleigh, NC
Marvin WoodallExecutive OfficerRaleigh, NC
Marvin WoodallPromoterRaleigh, NC
Paul A StewartDirectorMilwaukee, WI
John G CerminaroExecutive OfficerNew Britain, PA
David A. BonitaDirectorKingston, NJ
Keegan A. HarperDirectorKingston, NJ
Paul A. StewartDirectorKingston, NJ
Sam A. LiangDirectorKingston, NJ
Marvin J. WoodallDirectorKingston, NJ
Marvin J. WoodallExecutive OfficerKingston, NJ
John J. CerminaroExecutive OfficerKingston, NJ
Clay A. DeMarcusDirectorKingston, NJ
Michael J. CerminaroDirectorKingston, NJ

Other filings by this issuer (7)

FiledFormOfferingSold
2026-03-12D$51.1M$32.8M
2024-06-21D$5.0M$1.2M
2024-05-28D$4.8M$4.8M
2021-11-29D$5.0M$5.0M
2020-02-03D/A$9.8M
2018-04-17D/A$3.5M
2017-04-17D$1.5M$400K

More